Who are Benzalkonium Chloride-Benzocaine Topical's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/benzalkonium-chloride-benzocaine-topical.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Benzalkonium Chloride-Benzocaine Topical — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Benzalkonium Chloride-Benzocaine Topical (Benzalkonium Chloride-Benzocaine Topical) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antimicrobial-anesthetic combination. Area: Dermatology / Topical antisepsis.

marketed Topical antimicrobial-anesthetic combination Bacterial cell membranes (benzalkonium); sodium channels (benzocaine) Dermatology / Topical antisepsis Small molecule Live · refreshed every 30 min

Target snapshot

Benzalkonium Chloride-Benzocaine Topical (Benzalkonium Chloride-Benzocaine Topical) — Medice Arzneimittel Pütter GmbH & Co KG. Benzalkonium chloride acts as an antimicrobial agent while benzocaine provides local anesthetic effects through sodium channel blockade.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Benzalkonium Chloride-Benzocaine Topical TARGET	Benzalkonium Chloride-Benzocaine Topical	Medice Arzneimittel Pütter GmbH & Co KG	marketed	Topical antimicrobial-anesthetic combination	Bacterial cell membranes (benzalkonium); sodium channels (benzocaine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antimicrobial-anesthetic combination class)

Medice Arzneimittel Pütter GmbH & Co KG · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Benzalkonium Chloride-Benzocaine Topical — Competitive Intelligence Brief. https://druglandscape.com/ci/benzalkonium-chloride-benzocaine-topical. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab